Selective targeting of MYC mRNA by stabilized antisense oligonucleotides
Taylor Gill(Broad Institute), Christopher J. Ott(Broad Institute)
Cited by 16
Related Papers
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
|Nature|2016|629
Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies
|Cancer Cell|2019|361
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands
|Nature Chemical Biology|2018|229
DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming
|Cancer Discovery|2024|14
Targeted degradation of CDK9 potently disrupts the MYC-regulated network
|Cell chemical biology|2025|12